Abstract: A multi-module wearable device. According to an embodiment of the present disclosure, there is provided a system, including: a first wearable instrument; a second wearable instrument including a biometric sensor; an electrical connection between the first wearable instrument and the second wearable instrument; and a strap, sized and dimensioned to be disposed about a wrist. The electrical connection may be capable of connecting the first wearable instrument to the second wearable instrument when the second wearable instrument is at a first position on the strap relative to the first wearable instrument, and of connecting the first wearable instrument to the second wearable instrument when the second wearable instrument is at a second position on the strap relative to the first wearable instrument.

Abstract: A microfluidic apparatus includes a microfluidic chip for MicroOrganoSpheres (MOS) generation. A first channel is defined in a surface of the microfluidic chip and includes: a droplet generation portion including an inlet portion, a junction between the inlet portion and an emulsifying fluid channel, and a chamber downstream of the junction. A cross-sectional area of the chamber is larger than that of the inlet portion. The first channel includes a polymerization portion downstream of the droplet generation portion, the polymerization portion having a serpentine configuration. The apparatus includes a cartridge for MOS demulsification, including: a collection container; a substrate disposed on the collection container, and a membrane disposed between the collection container and the surface of the substrate. A second channel is defined in the surface of the substrate that faces the collection container and is fluidically connected to an output of the polymerization portion of the first channel.

Abstract: The disclosure relates to a femoral prosthesis device capable of preventing impingement and capable of being used with a constrained liner. In some examples, the device may include an elongated stem including a receiving section and a body section. The receiving section may have a bore. The device may include a calcar section including a through hole. The device may include an interface configured to be disposed on the receiving section between the body section and the proximal body. The device may include one or more fastener components configured to be disposed within the through hole and the bore when the stem and the proximal body are assembled so as to fasten/mate the elongated stem and the proximal body. When the stem and the proximal body are assembled and mated, the proximal body may be configured to radially rotate about the interface with respect to the elongated stem.

Abstract: A reflector including a substrate and a plurality of alternating layers of two materials having different indices of refraction disposed on the substrate, wherein the reflector exhibits a central peak in reflectance vs wavelength and the reflectance of the high-energy side-lobes is increased in intensity and the reflectance of the low-energy side-lobes is reduced in intensity and method for making the reflector is disclosed.

Abstract: The present invention provides a composition and method for treating diseases associated with demyelination of the nerves, such as ALS, RA, Tremors/Parkinson's Disease, and MS, Alzheimer's disease, ALS, Guillain-Barre syndrome, atherosclerosis, schizophrenia, Tremors/Parkinson's disease, senile dementia, Muscular Dystrophy, Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, Complex Regional Pain Syndrome, Diabetes, Neuropathic Pain, Spider Arthritis West Nile Virus, Fibromyalgia, Shingles, Gout, Migraine Headaches, Post Polio Syndrome, Central Virus Deafness, Asthma, Chronic Pain Of Unknown Origin and Hepatitis C and for treating non-viral based cancers. By administering measured doses of an immunity-provoking agent and a bacterial antigen activator, patients suffering from ALS, RA, MS, Tremors/Parkinson's Disease, and prostate cancer and others realized immediate beneficial results with no side effects.

Abstract: The present invention provides a composition and method for treating diseases associated with demyelination of the nerves, such as ALS, RA, Tremors/Parkinson's Disease, and MS, Alzheimer's disease, ALS, Guillain-Barre syndrome, atherosclerosis, schizophrenia, Tremors/Parkinson's disease, senile dementia, Muscular Dystrophy, Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, Complex Regional Pain Syndrome, Diabetes, Neuropathic Pain, Spider Arthritis West Nile Virus, Fibromyalgia, Shingles, Gout, Migraine Headaches, Post Polio Syndrome, Central Virus Deafness, Asthma, Chronic Pain Of Unknown Origin and Hepatitis C and for treating non-viral based cancers. By administering measured doses of an immunity-provoking agent and a bacterial antigen activator, patients suffering from ALS, RA, MS, Tremors/Parkinson's Disease, and prostate cancer and others realized immediate beneficial results with no side effects.

Abstract: The present invention provides a composition and method for treating diseases associated with demyelination of the nerves, such as ALS, RA, Tremors/Parkinson's Disease, and MS, Alzheimer's disease, ALS, Guillain-Barre syndrome, atherosclerosis, schizophrenia, Tremors/Parkinson's disease, senile dementia, Muscular Dystrophy, Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, Complex Regional Pain Syndrome, Diabetes, Neuropathic Pain, Spider Arthritis West Nile Virus,, Fibromyalgia, Shingles, Gout, Migraine Headaches, Post Polio Syndrome, Central Virus Deafness, Asthma, Chronic Pain Of Unknown Origin and Hepatitis C and for treating non-viral based cancers. By administering measured doses of an immunity-provoking agent and a bacterial antigen activator, patients suffering from ALS, RA, MS, Tremors/Parkinson's Disease, and prostate cancer and others realized immediate beneficial results with no side effects.

Abstract: Methods for determining the genetic predisposition of a human subject to developing renal disease, such as focal segmental glomerulosclerosis (FSGS) or end-stage kidney disease are provided herein. These methods include methods for detecting renal disease, or determining the risk of developing renal disease in a human subject, such as a subject of African ancestry. The methods utilize the detection of one or more haplotype blocks comprising at least two tag single nucleotide polymorphisms (SNPs) in a non-coding region of a MYH9 gene or detecting the presence of at least one tag SNP in a non-coding region of a MYH9 gene. An array for detecting a genetic predisposition to renal disease using probes complementary to the tag SNPs in the non-coding region of the MYH9 gene are also disclosed.

Abstract: Shingle material, preferably comprising a core with a capstock applied thereto is extruded, preferably by means of a co-extrusion process, onto a series of individual carrier plates, with the shingle material then being severed such that each carrier plate carries its own layer of shingle material thereon and the carrier plates are then delivered to a compression mold, in which the shingle is molded. The carrier plate and shingle is then removed from the mold and carried through a series of hold-down stations, after which the shingle is delivered to a trimmer, where flashing is simultaneously trimmed from its edges. The shingle is then cooled, preferably by sandwiching it between upper and lower retention members, which are cooled via a cooling tower. The retention members impart a curvature to the shingle. The carrier plates are returned via a return conveyor, to be heated, for re-use.

Abstract: A fluid delivery apparatus is provided for supplying a fluid mixture to a distillation column or reactor. The apparatus can be used to enhance the heat duty, the flow and/or the flow stability of an existing thermosiphon reboiler which supplies a heated fluid to the column or reactor. The apparatus includes an integrated eductor which receives and increases the fluid velocity of a supplemental fluid into which the heated fluid is aspirated to form a fluid mixture then delivered to the column or reactor. A process and a system utilizing the apparatus are also disclosed, as well as a method of retrofitting an existing system with the apparatus.

Abstract: A fluid delivery apparatus is provided for supplying a fluid mixture to a distillation column or reactor. The apparatus can be used to enhance the heat duty, the flow and/or the flow stability of an existing thermosiphon reboiler which supplies a heated fluid to the column or reactor. The apparatus includes an integrated eductor which receives and increases the fluid velocity of a supplemental fluid into which the heated fluid is aspirated to form a fluid mixture then delivered to the column or reactor. A process and a system utilizing the apparatus are also disclosed, as well as a method of retrofitting an existing system with the apparatus.

Abstract: A tray deck with a distillation column includes a sump suspended from the tray deck for receiving a liquid mixture from the tray deck, at least one vapor opening for rising vapor through the tray deck and at least one vapor baffle for receiving vapor passing through the vapor opening.

Abstract: Micro-fluid ejection devices, methods for making micro-fluid ejection, heads, and micro-fluid ejection heads having N actuators on a first substrate and logic capable of driving the N actuators on a second substrate. The ejection heads also have less than N electrical connections between the first and second substrates.

Abstract: A method for synchronizing a CDMA receiver to a transmitter when an adaptive antenna is utilized to receive transmitted data, wherein a receiving antenna system is adapted between a 360° reception angle pattern (i.e., an omni-directional pattern) and a fixed reception angle (i.e., a directional pattern) by permitting the receiver to identify a pilot signal having the largest magnitude. The receiver minimizes interference from other pilot signals by steering antenna pattern nulls toward other transmitters. As a result, the time required for the receiver to acquire a valid pilot signal is significantly reduced.

Abstract: Methods of increasing the cellular pool of A-CoA and thus driving the metabolic pathways in the direction of A-CoA containing metabolites by overexpressing rate limiting enzymes in A-CoA synthesis. Methods of increasing intracellular levels of CoA and A-CoA through genetic engineering of bacterial strains in conjunction with supplementation with precursor molecules.

Abstract: The present invention provides a composition and method for treating diseases associated with demyelination of the nerves, such as RA, Tremors/Parkinson's Disease, and MS, and for treating non-viral based cancers. By administering measured doses of an immunity-provoking agent and a bacterial antigen activator, patients suffering from RA, MS, Tremors/Parkinson's Disease, and prostrate cancer realized immediate beneficial results with no side effects.

Abstract: The present invention provides a composition and method for treating diseases associated with demyelination of the nerves, such as ALS, RA, Tremors/Parkinson's Disease, and MS, Alzheimer's disease, ALS, Guillain-Barre syndrome, atherosclerosis, schizophrenia, Tremors/Parkinsons's disease, senile dementia, Muscular Dystrophy, Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, Complex Regional Pain Syndrome, Diabetes, Neuropathic Pain, Spider Arthritis West Nile Virus, Fibromyalgia, Shingles, Gout, Migraine Headaches, Post Polio Syndrome, Central Virus Deafness, Asthma, Chronic Pain Of Unknown Origin and Hepatitis C and for treating non-viral based cancers. By administering measured doses of an immunity-provoking agent and a bacterial antigen activator, patients suffering from ALS, RA, MS, Tremors/Parkinson's Disease, and prostate cancer and others realized immediate beneficial results with no side effects.

Abstract: Methods for determining the genetic predisposition of a human subject to developing renal disease, such as focal segmental glomerulosclerosis (FSGS) or end-stage kidney disease are provided herein. These methods include methods for detecting renal disease, or determining the risk of developing renal disease in a human subject, such as a subject of African ancestry. The methods utilize the detection of one or more haplotype blocks comprising at least two tag single nucleotide polymorphisms (SNPs) in a non-coding region of a MYH9 gene or detecting the presence of at least one tag SNP in a non-coding region of a MYH9 gene. An array for detecting a genetic predisposition to renal disease using probes complementary to the tag SNPs in the non-coding region of the MYH9 gene are also disclosed.

Abstract: Shingle material, preferably comprising a core with a capstock applied thereto is extruded preferably by means of a co-extrusion process onto a series of Individual carrier plates, with the shingle material then being severed such that each carrier plate carries its own layer of shingle material thereon and the carrier plates are then delivered to a compression mold in which the shingle is molded. The carrier plate and shingle Is then removed from the mold and carried through a series of hold-down stations, after which the shingle is delivered to a trimmer, where flashing is simultaneously trimmed from its edges. The shingle Is then cooled, preferably by sandwiching it between upper and lower retention members which are cooled via a cooling tower. The retention members impart a curvature to the shingle.

Abstract: The present invention provides a composition and method for treating diseases associated with demyelination of the nerves, such as ALS, RA, Tremors/Parkinson's Disease, and MS, and for treating non-viral based cancers. By administering measured doses of an immunity-provoking agent and a bacterial antigen activator, patients suffering from ALS, RA, MS, Tremors/Parkinson's Disease, and prostrate cancer realized immediate beneficial results with no side effects.